Large health system pharmacies need to first identify their own contributions to health care disparities before identifying areas of opportunity to address the issue, said Aimee Loucks, PharmD, manager, specialty clinical pharmacy programs and formulary, Kaiser Permanente.
Large health system pharmacies need to first identify their own contributions to health care disparities before identifying areas of opportunity to address the issue, said Aimee Loucks, PharmD, manager, specialty clinical pharmacy programs and formulary, Kaiser Permanente.
Transcript
In larger health system pharmacies, what can pharmacists provide for patients with a high social determinant of health need and chronic disease?
One of the most important things that needs to happen first is that those larger health care systems need to identify their own contributions to health care disparities and examine what their biggest opportunities are. And then again, I think, you know, the most important thing that I've been learning as a part of this process, is that you really need to bring in the patients in those communities identify what their challenges are, and design solutions with them at the table and really implement to a type of patient-centered design.
I think another thing that large health care systems can do, in addition to meeting the needs of their individual patients in their community is to advocate that national goals or metrics are aligned with closing health care disparities to bring sort of a laser focus to this type of challenge.
What are some of the barriers that pharmacists in health systems face when trying to address a patient's social determinants of health issues?
I think one of the biggest barriers is probably that today their incentives are not aligned with taking the time to close those health care gaps. As we all know, our health care systems can be highly stressed and very focused on doing as much as possible as quickly as possible, and kind of moving things down the line to create sort of efficiencies in those process. And I think what we need to do, as a larger society, is figure out how we can customize the care that we provide to the individual patients that we provide care to knowing that some patients may need more help or a different type of help than we’re designed to provide today.
Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session
March 10th 2025The Conference for Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about the progress, and lack of progress, has been made in the fight against the HIV pandemic given the current political climate.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Reviving the Classics: The Role of Older Medications in Modern Dermatology
March 9th 2025Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.
Read More
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More